Understanding how GLP-1 therapy affects lipid parameters can help patients and clinicians make informed decisions about cardiovascular risk management
In an interventional study, it was shown that L-carnitine supplementation with a dose of 3 g/day for 12 weeks significantly reduced FBG, but its effects on HbA1c reduction were not significant in diabetic patients ( Subgroup analysis of our findings showed that trial duration, intervention dose, and BMI status significantly affect the insulin level, as well as, it was shown that trial duration, intervention dose, obesity, and health status have a significant effect on the HOMA-IR levels
Insurance, diagnosis and where you fill the prescription all play a role and most people don't know they have options
One final note: if you're drawing from the same vial multiple times per day, wipe the vial stopper with alcohol before every needle insertion to prevent bacterial contamination that compounds across dozens of draws
Buntz, B